Skip to main content

Table 2 Mortality Hazards Ratios

From: Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: A retrospective analysis

Characteristic Adjusted* Hazards Ratios (95% CI) P
Facility profit status   
   Not-for-profit Reference -
   For-profit 1.02 (0.99–1.06) 0.143
Facility affiliation   
   Freestanding Reference -
   Hospital-based 1.18 (1.14–1.23) < 0.0001
Year of dialysis inception   
   1998 Reference -
   1999 1.00 (0.97–1.02) 0.707
   2000 1.04 (1.01–1.07) 0.003
   2001 1.03 (1.00–1.06) 0.035
   2002 1.03 (1.00–1.06) 0.046
   2003 1.01 (0.98–1.04) 0.724
Age group (years)   
   ≤ 40 Reference -
   40 to 65 1.50 (1.44–1.57) < 0.0001
   > 65 2.34 (2.23–2.45) < 0.0001
Sex   
   Male 0.97 (0.96–0.99) < 0.0001
   Female Reference -
Race   
   White Reference -
   Black 0.78 (0.77–0.80) < 0.0001
   Other 0.76 (0.72–0.81) < 0.0001
Body mass index (kg/m2)   
   < 18.5 1.21 (1.17–1.25) < 0.0001
   18.5 to < 25 Reference -
   25 to < 30 0.84 (0.82–0.85) < 0.0001
   ≥ 30 0.76 (0.75–0.78) < 0.0001
Employment status   
   Employed Reference -
   Unemployed 1.20 (1.15–1.24) < 0.0001
   Retired 1.22 (1.18–1.27) < 0.0001
Cause of ESRD   
   Diabetes mellitus Reference -
   Hypertension 0.89 (0.88–0.91) < 0.0001
   Glomerulonephritis 0.73 (0.71–0.76) < 0.0001
   Other 0.99 (0.97–1.02) 0.490
Hospitalization (days)   
   0 Reference -
   0 to 5 1.13 (1.11–1.16) < 0.0001
   > 5 1.54 (1.50–1.57) < 0.0001
Infectious hospitalization 1.13 (1.10–1.16) < 0.0001
Atherosclerotic heart disease 1.06 (1.04–1.08) < 0.0001
Congestive heart failure 1.33 (1.31–1.36) < 0.0001
Stroke or TIA 1.19 (1.17–1.21) < 0.0001
Peripheral vascular disease 1.16 (1.14–1.17) < 0.0001
Dysrhythmia 1.25 (1.23–1.28) < 0.0001
Other cardiac disease 1.07 (1.05–1.10) < 0.0001
COPD 1.23 (1.21–1.26) < 0.0001
Gastrointestinal disease 1.21 (1.17–1.25) < 0.0001
Hepatic disease 1.07 (1.03–1.10) < 0.0001
Cancer 1.44 (1.41–1.48) < 0.0001
  1. COPD, chronic obstructive pulmonary disease; ESRD, end-stage renal disease. TIA, transient ischemic attack
  2. *Using proportional hazards regression with adjustment for for-profit status, facility affiliation, year of dialysis inception, age group, sex, race, body mass index, employment status, cause of ESRD, days of hospitalization, infectious hospitalization, and comorbid conditions.
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us